EAGLE GENOMICS LIMITED

EAGLE GENOMICS LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Persons with signficant control statements
  • Insolvency
  • Data Source
  • Overview

    Company NameEAGLE GENOMICS LIMITED
    Company StatusLiquidation
    Legal FormPrivate limited company
    Company Number 06587071
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryYes
    Registered Office is in DisputeNo

    What is the purpose of EAGLE GENOMICS LIMITED?

    • Business and domestic software development (62012) / Information and communication
    • Data processing, hosting and related activities (63110) / Information and communication
    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is EAGLE GENOMICS LIMITED located?

    Registered Office Address
    6th Floor 9 Appold Street
    EC2A 2AP London
    Undeliverable Registered Office AddressNo

    What are the latest accounts for EAGLE GENOMICS LIMITED?

    OverdueYes
    Next Accounts
    Next Accounts Period End OnMar 31, 2023
    Next Accounts Due OnDec 31, 2023
    Last Accounts
    Last Accounts Made Up ToMar 31, 2022

    What is the status of the latest confirmation statement for EAGLE GENOMICS LIMITED?

    OverdueYes
    Last Confirmation Statement Made Up ToJul 12, 2024
    Next Confirmation Statement DueJul 26, 2024
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToJul 12, 2023
    OverdueYes

    What are the latest filings for EAGLE GENOMICS LIMITED?

    Filings
    DateDescriptionDocumentType

    Liquidators' statement of receipts and payments to Mar 12, 2026

    20 pagesLIQ03

    Registered office address changed from 10 Lower Thames Street London EC3R 6AF to 6th Floor 9 Appold Street London EC2A 2AP on Dec 16, 2025

    3 pagesAD01

    Appointment of a voluntary liquidator

    3 pages600

    Notice of move from Administration case to Creditors Voluntary Liquidation

    39 pagesAM22

    Notice of administrator's death

    3 pagesAM18

    Administrator's progress report

    33 pagesAM10

    Statement of affairs with form AM02SOA/AM02SOC

    19 pagesAM02

    Result of meeting of creditors

    5 pagesAM07

    Statement of administrator's proposal

    65 pagesAM03

    Registered office address changed from Biodata Innovation Centre Wellcome Genome Campus Hinxton Cambridge Cambridgeshire CB10 1DR England to 10 Lower Thames Street London EC3R 6AF on Apr 04, 2024

    3 pagesAD01

    Appointment of an administrator

    3 pagesAM01

    Termination of appointment of John Schoellerman as a director on Feb 08, 2024

    1 pagesTM01

    Amended accounts for a small company made up to Mar 31, 2021

    26 pagesAAMD

    Amended accounts for a small company made up to Mar 31, 2020

    23 pagesAAMD

    Statement of capital following an allotment of shares on Dec 21, 2023

    • Capital: GBP 18,398.28
    4 pagesSH01

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of removal of pre-emption rights

    RES11
    capital

    Resolution of allotment of securities

    RES10

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of removal of pre-emption rights

    RES11
    capital

    Resolution of allotment of securities

    RES10

    Statement of capital following an allotment of shares on Oct 11, 2023

    • Capital: GBP 15,976.41
    4 pagesSH01

    Particulars of variation of rights attached to shares

    3 pagesSH10

    Resolutions

    Resolutions
    2 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of varying share rights or name

    RES12
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Change of share class name or designation

    2 pagesSH08

    Memorandum and Articles of Association

    73 pagesMA

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of removal of pre-emption rights

    RES11
    capital

    Resolution of allotment of securities

    RES10

    Appointment of Mr John Schoellerman as a director on Sep 27, 2023

    2 pagesAP01

    Statement of capital following an allotment of shares on Oct 04, 2023

    • Capital: GBP 3,906.13
    7 pagesSH01

    Who are the officers of EAGLE GENOMICS LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    HIGGS, Nigel
    Appold Street
    EC2A 2AP London
    6th Floor 9
    Secretary
    Appold Street
    EC2A 2AP London
    6th Floor 9
    314315050001
    GENIESER, Werner Robert
    20 Berkeley Square
    W1J 6EQ London
    Etf Partners
    England
    Director
    20 Berkeley Square
    W1J 6EQ London
    Etf Partners
    England
    United KingdomBritish160862380001
    GÉNY-STEPHANN, Delphine
    Appold Street
    EC2A 2AP London
    6th Floor 9
    Director
    Appold Street
    EC2A 2AP London
    6th Floor 9
    FranceFrench265068830001
    KIMONIDES, Victoria, Dr
    Appold Street
    EC2A 2AP London
    6th Floor 9
    Director
    Appold Street
    EC2A 2AP London
    6th Floor 9
    GreeceCypriot314311810001
    KÓBOR, Miklós
    Appold Street
    EC2A 2AP London
    6th Floor 9
    Director
    Appold Street
    EC2A 2AP London
    6th Floor 9
    HungaryHungarian275682140001
    WATSON, Alistair
    St. Andrew Square
    EH2 2AH Edinburgh
    6
    Scotland
    Director
    St. Andrew Square
    EH2 2AH Edinburgh
    6
    Scotland
    ScotlandBritish302230570001
    HORN, Gavin Alan
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    Secretary
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    247367270001
    O'CONNOR, Christopher Patrick
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    Secretary
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    184938080001
    BCS COSEC LIMITED
    c/o Business Consultancy Services (Bcs)
    Copley Hill Business Park
    Cambridge Road Babraham
    CB22 3GN Cambridge
    4 The Mill
    Cambridgeshire
    United Kingdom
    Secretary
    c/o Business Consultancy Services (Bcs)
    Copley Hill Business Park
    Cambridge Road Babraham
    CB22 3GN Cambridge
    4 The Mill
    Cambridgeshire
    United Kingdom
    Identification TypeEuropean Economic Area
    Registration Number4018490
    170590290001
    LEGALSURF REGISTRARS LIMITED
    St. Andrews House
    90 St. Andrews Road
    CB4 1DL Cambridge
    Legal Surfing Centre
    Cambridgeshire
    United Kingdom
    Secretary
    St. Andrews House
    90 St. Andrews Road
    CB4 1DL Cambridge
    Legal Surfing Centre
    Cambridgeshire
    United Kingdom
    128395360001
    AUSTIN, Clive
    Belvedere House
    130 Grosvenor Road
    SW1V 3JY London
    Flat 4
    England
    Director
    Belvedere House
    130 Grosvenor Road
    SW1V 3JY London
    Flat 4
    England
    EnglandBritish181635710001
    BARRELL, Alan Walter, Professor
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    Director
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    United KingdomBritish154571450001
    BIRNEY, John Frederick William, Prof
    Lancaster Road
    N4 4PL London
    77
    Director
    Lancaster Road
    N4 4PL London
    77
    United KingdomBritish136086180001
    FINBOW, Anthony Charles
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    Director
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    EnglandBritish164494760001
    FLANDERS, David John, Dr
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    Director
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    United KingdomBritish163075120001
    HARTEN-ASH, Vernon, Dr
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    Director
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    EnglandBritish63719380002
    HOLLAND, Richard Charles Geoffrey
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    Director
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    United KingdomBritish,New Zealander134430740002
    MELTZER, Clifford Bennett
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    Director
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    United StatesAmerican239117780001
    MUIR, Andrew Victor Graham, Dr
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    Director
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    EnglandBritish104054180002
    O'FARRELL, David John
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    Director
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    United KingdomBritish37072180003
    SCHOELLERMAN, John
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    Director
    Wellcome Genome Campus
    Hinxton
    CB10 1DR Cambridge
    Biodata Innovation Centre
    Cambridgeshire
    England
    United StatesAmerican314352670001
    SPOONER, William Hugo
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    Director
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    EnglandBritish130241960001
    THORPE, Simon Charles
    Wellcome Genome Campus
    CB10 1DR Hinxton
    Biodata Innovation Centre
    Cambridge
    United Kingdom
    Director
    Wellcome Genome Campus
    CB10 1DR Hinxton
    Biodata Innovation Centre
    Cambridge
    United Kingdom
    EnglandBritish216977690001
    URETA-VIDAL, Abel Javier, Dr
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    Director
    CB22 3AT Cambridge
    Babraham Research Campus
    United Kingdom
    United KingdomFrench130241950002

    Who are the persons with significant control of EAGLE GENOMICS LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Berkeley Square
    W1J 6EQ London
    20
    England
    Jan 22, 2019
    Berkeley Square
    W1J 6EQ London
    20
    England
    No
    Legal FormLimited Liability Partnership
    Country RegisteredEngland
    Legal AuthorityLimited Liabilty Partnerships Act 2000
    Place RegisteredCompanies House
    Registration NumberOc312083
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.

    What are the latest statements on persons with significant control for EAGLE GENOMICS LIMITED?

    Persons with signficant control statements
    Notified OnCeased OnStatement
    Mar 26, 2018Jan 22, 2019The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company
    May 07, 2017Mar 26, 2018The company has not yet completed taking reasonable steps to find out if there is anyone who is a registrable person or a registrable relevant legal entity in relation to the company

    Does EAGLE GENOMICS LIMITED have any insolvency cases?

    Case NumberDatesTypePractitionersOther
    1
    DateType
    Mar 20, 2024Administration started
    Mar 13, 2025Administration ended
    In administration
    NameRoleAddressAppointed OnCeased On
    Joseph Walter Colley
    10 Lower Thames Street
    EC3R 6AF London
    practitioner
    10 Lower Thames Street
    EC3R 6AF London
    John Anthony Dickinson
    10 Lower Thames Street
    EC3R 6AF London
    practitioner
    10 Lower Thames Street
    EC3R 6AF London
    2
    DateType
    Mar 13, 2025Commencement of winding up
    Creditors voluntary liquidation
    NameRoleAddressAppointed OnCeased On
    Joseph Walter Colley
    10 Lower Thames Street
    EC3R 6AF London
    practitioner
    10 Lower Thames Street
    EC3R 6AF London

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0